WASHINGTON - The FDA intends to catch up with advancing technology and science by implementing a plan to upgrade its system of monitoring the manufacturing facilities that make biologics, drugs and veterinarian products. (BioWorld Today)
WASHINGTON - The FDA intends to catch up with advancing technology and science by implementing a plan to upgrade its system of monitoring the manufacturing facilities that make biologics, drugs and veterinarian products. (BioWorld Today)
WASHINGTON - When a drug company asks the FDA to clear a product for marketing, the parties often agree that the company will conduct a postmarketing, or Phase IV, study. (BioWorld Today)
WASHINGTON - When a drug company asks the FDA to clear a product for marketing, the parties often agree that the company will conduct a postmarketing, or Phase IV, study. (BioWorld Today)
One of the scientists credited with mapping the human genome will lead three not-for-profit groups toward opening a lab where genomes will be expected to be sequenced quickly, accurately and at a cost-effective price. (BioWorld Today)
One of the scientists credited with mapping the human genome will lead three not-for-profit groups toward opening a lab where genomes will be expected to be sequenced quickly, accurately and at a cost-effective price. (BioWorld Today)
ImClone Systems Inc. filed a lawsuit against its founder and former CEO, Sam Waksal, claiming he destroyed documents possibly relevant to a government investigation of the company's business practices. (BioWorld Today)
ImClone Systems Inc. filed a lawsuit against its founder and former CEO, Sam Waksal, claiming he destroyed documents possibly relevant to a government investigation of the company's business practices. (BioWorld Today)
